Unknown

Dataset Information

Prognostic risk analysis related to radioresistance genes in colorectal cancer.


ABSTRACT:

Background

Radiotherapy (RT) is one of the most important treatments for patients with colorectal cancer (CRC). Radioresistance is the crucial cause of poor therapeutic outcomes in colorectal cancer. However, the underlying mechanism of radioresistance in colorectal cancer is still poorly defined. Herein we established a radioresistant colorectal cancer cell line and performed transcriptomics analyses to search for the underlying genes that contribute to radioresistance and investigate its association with the prognosis of CRC patients.

Methods

The radioresistant cell line was developed from the parental HCT116 cell by a stepwise increased dose of irradiation. Differential gene analysis was performed using cellular transcriptome data to identify genes associated with radiore

SUBMITTER: Qin H 

PROVIDER: S-EPMC9890073 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature